ES422961A1 - Procedimiento para preparar una suspension de virus. - Google Patents

Procedimiento para preparar una suspension de virus.

Info

Publication number
ES422961A1
ES422961A1 ES422961A ES422961A ES422961A1 ES 422961 A1 ES422961 A1 ES 422961A1 ES 422961 A ES422961 A ES 422961A ES 422961 A ES422961 A ES 422961A ES 422961 A1 ES422961 A1 ES 422961A1
Authority
ES
Spain
Prior art keywords
cell
free
viruses
preparations containing
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES422961A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RIT RECH IND THERAPEUT
Original Assignee
RIT RECH IND THERAPEUT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RIT RECH IND THERAPEUT filed Critical RIT RECH IND THERAPEUT
Publication of ES422961A1 publication Critical patent/ES422961A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16351—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16751—Methods of production or purification of viral material

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES422961A 1973-02-09 1974-02-06 Procedimiento para preparar una suspension de virus. Expired ES422961A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US330912A US3915794A (en) 1973-02-09 1973-02-09 Stabilizing compositions for cell-free viruses and cell-free virus preparations containing them

Publications (1)

Publication Number Publication Date
ES422961A1 true ES422961A1 (es) 1976-06-01

Family

ID=23291840

Family Applications (1)

Application Number Title Priority Date Filing Date
ES422961A Expired ES422961A1 (es) 1973-02-09 1974-02-06 Procedimiento para preparar una suspension de virus.

Country Status (18)

Country Link
US (1) US3915794A ( )
JP (1) JPS5732043B2 ( )
AT (1) AT331398B ( )
BE (1) BE810555A ( )
CA (1) CA1035700A ( )
CH (1) CH592143A5 ( )
DD (1) DD110306A5 ( )
DE (1) DE2406167C2 ( )
DK (1) DK134032B ( )
ES (1) ES422961A1 ( )
FR (1) FR2216997B1 ( )
GB (1) GB1452344A ( )
HU (1) HU169120B ( )
IE (1) IE38825B1 ( )
IL (1) IL44011A ( )
NL (1) NL178013C ( )
SE (1) SE427799B ( )
ZA (1) ZA74163B ( )

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT71926B (en) * 1979-10-29 1982-03-31 Merck & Co Inc Process for preparing a liquid vaccine comprising a stabilizer
JPS57114527A (en) * 1979-10-29 1982-07-16 Merck & Co Inc Vaccine stabilizer
US4273762A (en) * 1979-12-03 1981-06-16 Merck & Co., Inc. Lyophilization process for live viral compositions
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
JPS6314729A (ja) * 1986-06-30 1988-01-21 スミスクライン・バイオロジカルス・ソシエテ・アノニム 生ワクチン用改良安定剤、その製造法およびそれを含有するワクチン
US4847078A (en) * 1987-01-14 1989-07-11 Arseco, Inc. Storage stable topical composition having moisture control agent
JPH01112853U ( ) * 1988-01-27 1989-07-28
US5045446A (en) * 1988-08-26 1991-09-03 Cryopharm Corporation Lyophilization of cells
IL90188A0 (en) * 1988-05-18 1989-12-15 Cryopharm Corp Process and medium for the lyophilization of erythrocytes
WO1991018504A1 (en) * 1990-05-25 1991-12-12 Cryopharm Corporation Process for lyophilizing cells, cell-like materials and platelets in a mixture of biocompatible amphipathic polymers
CA2075521C (en) * 1992-05-05 1995-11-28 Kuniaki Koyama Stabilized live vaccine
AU4392193A (en) * 1992-06-04 1993-12-30 Merck & Co., Inc. Process for attenuated varicella zoster virus vaccine production
US5360736A (en) * 1992-06-04 1994-11-01 Merck & Co., Inc. Process for attenuated varicella zoster virus vaccine production
JPH09504429A (ja) * 1993-10-12 1997-05-06 チロン ビアジーン，インコーポレイティド 組換えウイルスの保存方法
ZA973642B (en) * 1996-04-26 1997-11-25 Merck & Co Inc DNA vaccine formulations.
DE69732029T2 (de) * 1996-04-26 2006-02-23 Merck & Co., Inc. Dna enthaltende impfstoffen
US6051238A (en) * 1996-12-20 2000-04-18 Merck & Co., Inc. Stabilizers for lyophilized mumps vaccines
US6210683B1 (en) 1997-09-05 2001-04-03 Merck & Co., Inc. Stabilizers containing recombinant human serum albumin for live virus vaccines
DE19812940A1 (de) * 1998-03-24 1999-10-07 Medigene Ag Formulierung mit Papillomavirus-spezifischem Protein, seine Herstellung und Verwendung
US6926897B1 (en) * 1998-03-24 2005-08-09 Medigene Aktiengesellschaft Medicament for the avoidance or treatment of papillomavirus-specific tumour
GB9808922D0 (en) * 1998-04-24 1998-06-24 Cantab Pharmaceuticals Res Ltd Virus preparations
US6225289B1 (en) 1998-12-10 2001-05-01 Genvec, Inc. Methods and compositions for preserving adenoviral vectors
FR2814957B1 (fr) 2000-10-06 2002-12-20 Aventis Pasteur Composition vaccinale et procede de stabilisation
US7013940B2 (en) * 2001-04-19 2006-03-21 Michelin Recherche Et Technique S.A. Device for attenuating cavity noise in a tire and wheel
WO2003053463A2 (en) * 2001-12-10 2003-07-03 Bavarian Nordic A/S Poxvirus-containing compositions and process for their preparation
TWI398272B (zh) * 2005-03-08 2013-06-11 Intervet Int Bv 化學定義的安定劑
EP1870649A1 (en) 2006-06-20 2007-12-26 Octapharma AG Lyophilisation targetting defined residual moisture by limited desorption energy levels
US10166188B2 (en) 2011-08-12 2019-01-01 Merial, Inc. Method for vacuum-assisted preservation of biologics including vaccines
TWI690322B (zh) * 2012-10-02 2020-04-11 法商傳斯堅公司 含病毒的調配物及其使用
CA2948845C (en) 2014-05-14 2022-05-31 Merial, Inc. Methods for freeze-drying and rehydrating biologics
EP3226894B1 (en) 2014-12-01 2019-08-07 Transgene SA Stable liquid vaccinia virus formulations
CN105999287A (zh) * 2016-07-01 2016-10-12 广东圣戈生物科技有限公司 一种疫苗稀释液及其制备方法
EP3522871B1 (en) 2016-10-05 2021-11-17 Zoetis Services LLC Lyophilization methods that provide stably dehydrated protozoans for use as potent live vaccines
US20200308550A1 (en) 2017-09-11 2020-10-01 Imba - Institut Für Molekulare Biotechnologie Gmbh Tumor organoid model

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1292803A (en) * 1968-11-18 1972-10-11 Nat Res Dev Improvements relating to the production of antigens
US3642574A (en) * 1970-04-29 1972-02-15 Us Agriculture Method for producing vaccine for immunization of poultry against marek{3 s disease
US3783098A (en) * 1971-08-10 1974-01-01 Cornell Res Foundation Inc Highly potent,viable and stable cellfree virus preparations from cells infected with cell-associated viruses and method for obtaining the same

Also Published As

Publication number Publication date
DK134032B (da) 1976-08-30
DK134032C ( ) 1977-02-07
DE2406167A1 (de) 1974-08-15
HU169120B ( ) 1976-09-28
NL7401786A ( ) 1974-08-13
IL44011A0 (en) 1974-05-16
ZA74163B (en) 1974-11-27
IE38825L (en) 1974-08-09
FR2216997A1 ( ) 1974-09-06
NL178013B (nl) 1985-08-01
FR2216997B1 ( ) 1978-01-06
JPS5732043B2 ( ) 1982-07-08
SE427799B (sv) 1983-05-09
IE38825B1 (en) 1978-06-07
AT331398B (de) 1976-08-25
US3915794A (en) 1975-10-28
CH592143A5 ( ) 1977-10-14
CA1035700A (en) 1978-08-01
IL44011A (en) 1977-04-29
DE2406167C2 (de) 1984-12-20
DD110306A5 ( ) 1974-12-12
GB1452344A (en) 1976-10-13
BE810555A (fr) 1974-08-05
AU6486574A (en) 1975-07-24
ATA98274A (de) 1975-11-15
NL178013C (nl) 1986-01-02
JPS49109518A ( ) 1974-10-18

Similar Documents

Publication Publication Date Title
ES422961A1 (es) Procedimiento para preparar una suspension de virus.
DE2861729D1 (en) Aliphatic derivatives of phosphonoformic acid, pharmaceutical compositions and methods for combating virus infections
IL48642A (en) 3-amino-indazolecarboxylic acid derivatives,ther preparation and pharmaceutical compositions containing them
IL47269A0 (en) New phenylguanidine derivatives,their preparation and pharmaceutical compositions containing them
IL47360A (en) -amino- and -formyl- -(p-acycloxyphenyl) acetamido-3-cephem-4-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL44143A0 (en) Method of inactivating viruses and vaccines prepared thereby
ES428949A1 (es) Procedimiento para la preparacion de derivados de acidos quinolin-8-carboxilicos.
KE2900A (en) N-(1-benzylpiperid-4-yl)-benzamides, methods for their preparation and pharmaceutical compositions containing them
IL47149A0 (en) New amino acid derivatives,their preparation and pharmaceutical compositions containing them
IL45589A0 (en) Live influenza virus vaccines and preparation thereof
JPS5218811A (en) Preparation of aqueous solution of fat- soluble substances
HU175157B (hu) Sposob poluchenija 0,s-dialkil-0-fenil-tiofenil-fosfotiolatnykh proizvodnykh i pesticidnye preparaty soderzhashchie takie soedinenija kak aktivnye veshchestva
IT1049427B (it) Derivati attivi di metilammina composizioni terapeutiche contenenti la stessa e procedimenti per preparare detti derivati e composizioni
IL39126A (en) 2-(2'-alkylamino-1'-hydroxyethyl)benzofuran derivatives,their preparation and pharmaceutical compositions containing them
PH11064A (en) Viable,stable,cell-free virus suspension
IL47519A (en) 7-sulphinimidoyl(sulphimidoyl)-xanthone-2-carboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
IT1114869B (it) Derivati attivi di metilammina,composizioni terapeutiche che li contengono e procedimenti per preparare i detti derivati e le dette composizioni
AU482558B2 (en) Stabilizing compositions for cell-free viruses and cell-free virus preparations containing them
AU2091370A (en) Improvements; in virus vaccines
IL48096A0 (en) Novel indole derivatives,their preparation and pharmaceutical compositions containing them
CA960586A (en) Infectious bovine rhinotracheitis virus vaccine and method of preparing and using the same
IL47414A0 (en) New benzodioxan derivatives,their preparation and insecticidal and acaricidal compositions containing them
AU457758B2 (en) Infectious bovine rhinotracheitis virus vaccine and method of preparing and using thesame
AU486332B2 (en) N-[3-alkanoyl-4-(3-amino-2-hydroxy) propoxy-phenyl] ureas, methods for their preparation and compositions containing them
ZA711290B (en) Novel 16-methylene-9beta,10alpha steroid compounds,pharmaceutical preparations which contain the novel compounds as active ingredients,and methods of producing the said compounds and preparations